iShares ESG Aware 1-5 Year USD Corporate Bond ETF (SUSB)
Live price chart, market sentiment, and community perspectives for iShares ESG Aware 1-5 Year USD Corporate Bond ETF (NASDAQ: SUSB).
Live price chart, market sentiment, and community perspectives for iShares ESG Aware 1-5 Year USD Corporate Bond ETF (NASDAQ: SUSB).
Dealer gamma exposure on SUSB creates elevated volatility near the current strike cluster. Not adding exposure until after the backlog data clears.
On our desk, the institutional flow for SUSB looks robust. During Q2 2026, we tracked 349 hedge funds and large institutions holding $976 million, with 195 increasing their positions. Total fund ownership climbed over six percent to 75.53%. This heavy institutional backing validates the product as a reliable short-term parking vehicle, especially when short-term yields sit comfortably between 4.5% and 5.0%, beating out legacy bank savings and cash equivalents by over 100 basis points.
Watching the technical charts and recent data feeds, I am advising caution despite the fundamental yield appeal. SUSB's technical summaries across multiple timeframes—from 5-minute up to monthly—are flashing 'Strong Sell' with 12 sell signals against zero buys. Furthermore, recent filings highlight significant growth in short interest as of mid-August 2026. While the 30-day SEC yield of 4.77% and a modest 0.12% expense ratio are attractive, these technical headwinds and rising short bets suggest potential friction ahead for near-term price momentum.
From a quantitative perspective, when evaluating SUSB's risk-reward profile, we must balance the macroeconomic backdrop against structural portfolio metrics. The ETF tracks an index of short-term, investment-grade, U.S. dollar corporate bonds with ESG screening, maintaining a 12-month trailing yield of 4.53% and a year-to-date total return of 1.02% as of August 2026. With $1.31 billion in total assets and a low 34% turnover rate, the strategy minimizes duration risk relative to longer-term bond funds, making it an efficient tool for capturing a meaningful yield advantage without extreme rate sensitivity.
Explore plasma cleansing, somatic organ swaps, and BCI.